サマリー

ラコサミド錠の世界市場規模は、2022年の100万米ドルから2029年には100万米ドルになると予測されており、2023年から2029年までの年平均成長率は %と予想されています。
ラコサミド錠の米国市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年には百万米ドルに増加すると予測されています。
ラコサミド錠の中国市場は、2023年から2029年までの年平均成長率で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定されます。
ラコサミド錠のヨーロッパ市場は、2023年から2029年までのCAGR %で、2022年の百万米ドルから2029年までに百万米ドルに増加すると推定されます。
世界の主要なLacosamide Tabletsプレーヤーは、UCB、Aesica Pharmaceuticals GmbH、Teva、MSN Laboratories、Alembic Pharma、Glenmark、Accord Healthcare、Mylan、Sun PharmaApotexなどです。収益面では、世界の2大企業が2022年にほぼ％のシェアを占めています。
ラコサミド錠は抗てんかん薬で、焦点発作（脳の1つの部位で始まる発作）を治療するために、他の抗てんかん薬に追加して使用すること（「補完療法」）が可能な薬剤です。
LPI（エルピーアイ）の最新リサーチレポート「ラコサミド錠の業界予測」は、過去の販売実績から2022年の世界のラコサミド錠の総販売実績を検証し、2023年から2029年のラコサミド錠の販売予測について地域や市場分野ごとに包括的な分析を提供しています。ラコサミド錠の売上を地域別、市場分野別、サブセクター別に分類し、世界のラコサミド錠産業の詳細な分析（百万米ドル）を提供します。
本インサイトレポートでは、世界のラコサミド錠の状況を包括的に分析し、製品区分、会社設立、収益、市場シェア、最新開発、M&A活動に関する主要動向を明らかにしています。また、本レポートでは、ラコサミド錠のポートフォリオと能力、市場参入戦略、市場ポジション、地理的フットプリントに焦点を当てて、世界の主要企業の戦略を分析し、加速する世界のラコサミド錠市場におけるこれらの企業の独自のポジションをより良く理解します。
本インサイトレポートでは、ラコサミド錠の世界的な見通しを形成する主要な市場動向、推進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を行い、新たな機会のポケットを明らかにします。何百ものボトムアップの定性的・定量的な市場インプットに基づく透明性の高い手法により、本調査予測は世界のラコサミド錠の現状と将来の軌道について非常にニュアンスのある見方を提供します。
本レポートでは、ラコサミド錠市場の製品タイプ、用途、主要メーカー、主要地域・国別の包括的な概要、市場シェア、成長機会について紹介します。
市場のセグメンテーション
タイプ別セグメンテーション
50mg/錠剤
100 mg/錠
150 mg/tablet
200mg/tablet
用途別セグメント
大人
小児
また、本レポートでは、地域別に市場を分割しています：
米州
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
中近東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した上で選定されています。
UCB
アエシカ・ファーマシューティカルズGmbH
テバ
MSNラボラトリーズ
アレンビック・ファーマ
グレンマーク
アコードヘルスケア
マイラン
サンファーマアポテックス
江西清風製薬
北京四川製薬
ブチャン製薬
本レポートで取り上げる主な質問
世界のラコサミド錠市場の10年後の展望は？
世界および地域別に、ラコサミド錠の市場成長を促進する要因は何か？
市場別、地域別に最も速い成長を遂げる技術は何か？
ラコサミド錠の市場機会はエンドマーケットの規模によってどのように異なるのか？
Lacosamide Tabletsのタイプ、アプリケーションの内訳は？
COVID-19とロシア・ウクライナ戦争の影響力は？

ページTOPに戻る

目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lacosamide Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Lacosamide Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Lacosamide Tablets by Country/Region, 2018, 2022 & 2029
2.2 Lacosamide Tablets Segment by Type
2.2.1 50 mg/tablet
2.2.2 100 mg/tablet
2.2.3 150 mg/tablet
2.2.4 200 mg/tablet
2.3 Lacosamide Tablets Sales by Type
2.3.1 Global Lacosamide Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Lacosamide Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Lacosamide Tablets Sale Price by Type (2018-2023)
2.4 Lacosamide Tablets Segment by Application
2.4.1 Adults
2.4.2 Children
2.5 Lacosamide Tablets Sales by Application
2.5.1 Global Lacosamide Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Lacosamide Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Lacosamide Tablets Sale Price by Application (2018-2023)
3 Global Lacosamide Tablets by Company
3.1 Global Lacosamide Tablets Breakdown Data by Company
3.1.1 Global Lacosamide Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Lacosamide Tablets Sales Market Share by Company (2018-2023)
3.2 Global Lacosamide Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Lacosamide Tablets Revenue by Company (2018-2023)
3.2.2 Global Lacosamide Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Lacosamide Tablets Sale Price by Company
3.4 Key Manufacturers Lacosamide Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lacosamide Tablets Product Location Distribution
3.4.2 Players Lacosamide Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lacosamide Tablets by Geographic Region
4.1 World Historic Lacosamide Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Lacosamide Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Lacosamide Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Lacosamide Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Lacosamide Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Lacosamide Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Lacosamide Tablets Sales Growth
4.4 APAC Lacosamide Tablets Sales Growth
4.5 Europe Lacosamide Tablets Sales Growth
4.6 Middle East & Africa Lacosamide Tablets Sales Growth
5 Americas
5.1 Americas Lacosamide Tablets Sales by Country
5.1.1 Americas Lacosamide Tablets Sales by Country (2018-2023)
5.1.2 Americas Lacosamide Tablets Revenue by Country (2018-2023)
5.2 Americas Lacosamide Tablets Sales by Type
5.3 Americas Lacosamide Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lacosamide Tablets Sales by Region
6.1.1 APAC Lacosamide Tablets Sales by Region (2018-2023)
6.1.2 APAC Lacosamide Tablets Revenue by Region (2018-2023)
6.2 APAC Lacosamide Tablets Sales by Type
6.3 APAC Lacosamide Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lacosamide Tablets by Country
7.1.1 Europe Lacosamide Tablets Sales by Country (2018-2023)
7.1.2 Europe Lacosamide Tablets Revenue by Country (2018-2023)
7.2 Europe Lacosamide Tablets Sales by Type
7.3 Europe Lacosamide Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lacosamide Tablets by Country
8.1.1 Middle East & Africa Lacosamide Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Lacosamide Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Lacosamide Tablets Sales by Type
8.3 Middle East & Africa Lacosamide Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lacosamide Tablets
10.3 Manufacturing Process Analysis of Lacosamide Tablets
10.4 Industry Chain Structure of Lacosamide Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lacosamide Tablets Distributors
11.3 Lacosamide Tablets Customer
12 World Forecast Review for Lacosamide Tablets by Geographic Region
12.1 Global Lacosamide Tablets Market Size Forecast by Region
12.1.1 Global Lacosamide Tablets Forecast by Region (2024-2029)
12.1.2 Global Lacosamide Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lacosamide Tablets Forecast by Type
12.7 Global Lacosamide Tablets Forecast by Application
13 Key Players Analysis
13.1 UCB
13.1.1 UCB Company Information
13.1.2 UCB Lacosamide Tablets Product Portfolios and Specifications
13.1.3 UCB Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 UCB Main Business Overview
13.1.5 UCB Latest Developments
13.2 Aesica Pharmaceuticals GmbH
13.2.1 Aesica Pharmaceuticals GmbH Company Information
13.2.2 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product Portfolios and Specifications
13.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Aesica Pharmaceuticals GmbH Main Business Overview
13.2.5 Aesica Pharmaceuticals GmbH Latest Developments
13.3 Teva
13.3.1 Teva Company Information
13.3.2 Teva Lacosamide Tablets Product Portfolios and Specifications
13.3.3 Teva Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Teva Main Business Overview
13.3.5 Teva Latest Developments
13.4 MSN Laboratories
13.4.1 MSN Laboratories Company Information
13.4.2 MSN Laboratories Lacosamide Tablets Product Portfolios and Specifications
13.4.3 MSN Laboratories Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MSN Laboratories Main Business Overview
13.4.5 MSN Laboratories Latest Developments
13.5 Alembic Pharma
13.5.1 Alembic Pharma Company Information
13.5.2 Alembic Pharma Lacosamide Tablets Product Portfolios and Specifications
13.5.3 Alembic Pharma Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Alembic Pharma Main Business Overview
13.5.5 Alembic Pharma Latest Developments
13.6 Glenmark
13.6.1 Glenmark Company Information
13.6.2 Glenmark Lacosamide Tablets Product Portfolios and Specifications
13.6.3 Glenmark Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Glenmark Main Business Overview
13.6.5 Glenmark Latest Developments
13.7 Accord Healthcare
13.7.1 Accord Healthcare Company Information
13.7.2 Accord Healthcare Lacosamide Tablets Product Portfolios and Specifications
13.7.3 Accord Healthcare Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Accord Healthcare Main Business Overview
13.7.5 Accord Healthcare Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Lacosamide Tablets Product Portfolios and Specifications
13.8.3 Mylan Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Sun PharmaApotex
13.9.1 Sun PharmaApotex Company Information
13.9.2 Sun PharmaApotex Lacosamide Tablets Product Portfolios and Specifications
13.9.3 Sun PharmaApotex Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Sun PharmaApotex Main Business Overview
13.9.5 Sun PharmaApotex Latest Developments
13.10 Jiangxi Qingfeng Pharmaceutical
13.10.1 Jiangxi Qingfeng Pharmaceutical Company Information
13.10.2 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jiangxi Qingfeng Pharmaceutical Main Business Overview
13.10.5 Jiangxi Qingfeng Pharmaceutical Latest Developments
13.11 Beijing Sihuan Pharmaceutical
13.11.1 Beijing Sihuan Pharmaceutical Company Information
13.11.2 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Beijing Sihuan Pharmaceutical Main Business Overview
13.11.5 Beijing Sihuan Pharmaceutical Latest Developments
13.12 Buchang Pharmaceutical
13.12.1 Buchang Pharmaceutical Company Information
13.12.2 Buchang Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
13.12.3 Buchang Pharmaceutical Lacosamide Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Buchang Pharmaceutical Main Business Overview
13.12.5 Buchang Pharmaceutical Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

図表リスト

List of Tables
Table 1. Lacosamide Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Lacosamide Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 50 mg/tablet
Table 4. Major Players of 100 mg/tablet
Table 5. Major Players of 150 mg/tablet
Table 6. Major Players of 200 mg/tablet
Table 7. Global Lacosamide Tablets Sales by Type (2018-2023) & (K Units)
Table 8. Global Lacosamide Tablets Sales Market Share by Type (2018-2023)
Table 9. Global Lacosamide Tablets Revenue by Type (2018-2023) & ($ million)
Table 10. Global Lacosamide Tablets Revenue Market Share by Type (2018-2023)
Table 11. Global Lacosamide Tablets Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Lacosamide Tablets Sales by Application (2018-2023) & (K Units)
Table 13. Global Lacosamide Tablets Sales Market Share by Application (2018-2023)
Table 14. Global Lacosamide Tablets Revenue by Application (2018-2023)
Table 15. Global Lacosamide Tablets Revenue Market Share by Application (2018-2023)
Table 16. Global Lacosamide Tablets Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Lacosamide Tablets Sales by Company (2018-2023) & (K Units)
Table 18. Global Lacosamide Tablets Sales Market Share by Company (2018-2023)
Table 19. Global Lacosamide Tablets Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Lacosamide Tablets Revenue Market Share by Company (2018-2023)
Table 21. Global Lacosamide Tablets Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Lacosamide Tablets Producing Area Distribution and Sales Area
Table 23. Players Lacosamide Tablets Products Offered
Table 24. Lacosamide Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Lacosamide Tablets Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Lacosamide Tablets Sales Market Share Geographic Region (2018-2023)
Table 29. Global Lacosamide Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Lacosamide Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Lacosamide Tablets Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Lacosamide Tablets Sales Market Share by Country/Region (2018-2023)
Table 33. Global Lacosamide Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Lacosamide Tablets Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Lacosamide Tablets Sales by Country (2018-2023) & (K Units)
Table 36. Americas Lacosamide Tablets Sales Market Share by Country (2018-2023)
Table 37. Americas Lacosamide Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Lacosamide Tablets Revenue Market Share by Country (2018-2023)
Table 39. Americas Lacosamide Tablets Sales by Type (2018-2023) & (K Units)
Table 40. Americas Lacosamide Tablets Sales by Application (2018-2023) & (K Units)
Table 41. APAC Lacosamide Tablets Sales by Region (2018-2023) & (K Units)
Table 42. APAC Lacosamide Tablets Sales Market Share by Region (2018-2023)
Table 43. APAC Lacosamide Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Lacosamide Tablets Revenue Market Share by Region (2018-2023)
Table 45. APAC Lacosamide Tablets Sales by Type (2018-2023) & (K Units)
Table 46. APAC Lacosamide Tablets Sales by Application (2018-2023) & (K Units)
Table 47. Europe Lacosamide Tablets Sales by Country (2018-2023) & (K Units)
Table 48. Europe Lacosamide Tablets Sales Market Share by Country (2018-2023)
Table 49. Europe Lacosamide Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Lacosamide Tablets Revenue Market Share by Country (2018-2023)
Table 51. Europe Lacosamide Tablets Sales by Type (2018-2023) & (K Units)
Table 52. Europe Lacosamide Tablets Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Lacosamide Tablets Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Lacosamide Tablets Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Lacosamide Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Lacosamide Tablets Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Lacosamide Tablets Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Lacosamide Tablets Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Lacosamide Tablets
Table 60. Key Market Challenges & Risks of Lacosamide Tablets
Table 61. Key Industry Trends of Lacosamide Tablets
Table 62. Lacosamide Tablets Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Lacosamide Tablets Distributors List
Table 65. Lacosamide Tablets Customer List
Table 66. Global Lacosamide Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Lacosamide Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Lacosamide Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Lacosamide Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Lacosamide Tablets Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Lacosamide Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Lacosamide Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Lacosamide Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Lacosamide Tablets Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Lacosamide Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Lacosamide Tablets Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Lacosamide Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Lacosamide Tablets Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Lacosamide Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. UCB Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 81. UCB Lacosamide Tablets Product Portfolios and Specifications
Table 82. UCB Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. UCB Main Business
Table 84. UCB Latest Developments
Table 85. Aesica Pharmaceuticals GmbH Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 86. Aesica Pharmaceuticals GmbH Lacosamide Tablets Product Portfolios and Specifications
Table 87. Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Aesica Pharmaceuticals GmbH Main Business
Table 89. Aesica Pharmaceuticals GmbH Latest Developments
Table 90. Teva Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 91. Teva Lacosamide Tablets Product Portfolios and Specifications
Table 92. Teva Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Teva Main Business
Table 94. Teva Latest Developments
Table 95. MSN Laboratories Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 96. MSN Laboratories Lacosamide Tablets Product Portfolios and Specifications
Table 97. MSN Laboratories Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. MSN Laboratories Main Business
Table 99. MSN Laboratories Latest Developments
Table 100. Alembic Pharma Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 101. Alembic Pharma Lacosamide Tablets Product Portfolios and Specifications
Table 102. Alembic Pharma Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Alembic Pharma Main Business
Table 104. Alembic Pharma Latest Developments
Table 105. Glenmark Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 106. Glenmark Lacosamide Tablets Product Portfolios and Specifications
Table 107. Glenmark Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Glenmark Main Business
Table 109. Glenmark Latest Developments
Table 110. Accord Healthcare Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 111. Accord Healthcare Lacosamide Tablets Product Portfolios and Specifications
Table 112. Accord Healthcare Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Accord Healthcare Main Business
Table 114. Accord Healthcare Latest Developments
Table 115. Mylan Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 116. Mylan Lacosamide Tablets Product Portfolios and Specifications
Table 117. Mylan Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Mylan Main Business
Table 119. Mylan Latest Developments
Table 120. Sun PharmaApotex Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 121. Sun PharmaApotex Lacosamide Tablets Product Portfolios and Specifications
Table 122. Sun PharmaApotex Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Sun PharmaApotex Main Business
Table 124. Sun PharmaApotex Latest Developments
Table 125. Jiangxi Qingfeng Pharmaceutical Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 126. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
Table 127. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Jiangxi Qingfeng Pharmaceutical Main Business
Table 129. Jiangxi Qingfeng Pharmaceutical Latest Developments
Table 130. Beijing Sihuan Pharmaceutical Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 131. Beijing Sihuan Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
Table 132. Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Beijing Sihuan Pharmaceutical Main Business
Table 134. Beijing Sihuan Pharmaceutical Latest Developments
Table 135. Buchang Pharmaceutical Basic Information, Lacosamide Tablets Manufacturing Base, Sales Area and Its Competitors
Table 136. Buchang Pharmaceutical Lacosamide Tablets Product Portfolios and Specifications
Table 137. Buchang Pharmaceutical Lacosamide Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Buchang Pharmaceutical Main Business
Table 139. Buchang Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Lacosamide Tablets
Figure 2. Lacosamide Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lacosamide Tablets Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Lacosamide Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Lacosamide Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 50 mg/tablet
Figure 10. Product Picture of 100 mg/tablet
Figure 11. Product Picture of 150 mg/tablet
Figure 12. Product Picture of 200 mg/tablet
Figure 13. Global Lacosamide Tablets Sales Market Share by Type in 2022
Figure 14. Global Lacosamide Tablets Revenue Market Share by Type (2018-2023)
Figure 15. Lacosamide Tablets Consumed in Adults
Figure 16. Global Lacosamide Tablets Market: Adults (2018-2023) & (K Units)
Figure 17. Lacosamide Tablets Consumed in Children
Figure 18. Global Lacosamide Tablets Market: Children (2018-2023) & (K Units)
Figure 19. Global Lacosamide Tablets Sales Market Share by Application (2022)
Figure 20. Global Lacosamide Tablets Revenue Market Share by Application in 2022
Figure 21. Lacosamide Tablets Sales Market by Company in 2022 (K Units)
Figure 22. Global Lacosamide Tablets Sales Market Share by Company in 2022
Figure 23. Lacosamide Tablets Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Lacosamide Tablets Revenue Market Share by Company in 2022
Figure 25. Global Lacosamide Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Lacosamide Tablets Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Lacosamide Tablets Sales 2018-2023 (K Units)
Figure 28. Americas Lacosamide Tablets Revenue 2018-2023 ($ Millions)
Figure 29. APAC Lacosamide Tablets Sales 2018-2023 (K Units)
Figure 30. APAC Lacosamide Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Europe Lacosamide Tablets Sales 2018-2023 (K Units)
Figure 32. Europe Lacosamide Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Lacosamide Tablets Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Lacosamide Tablets Revenue 2018-2023 ($ Millions)
Figure 35. Americas Lacosamide Tablets Sales Market Share by Country in 2022
Figure 36. Americas Lacosamide Tablets Revenue Market Share by Country in 2022
Figure 37. Americas Lacosamide Tablets Sales Market Share by Type (2018-2023)
Figure 38. Americas Lacosamide Tablets Sales Market Share by Application (2018-2023)
Figure 39. United States Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Lacosamide Tablets Sales Market Share by Region in 2022
Figure 44. APAC Lacosamide Tablets Revenue Market Share by Regions in 2022
Figure 45. APAC Lacosamide Tablets Sales Market Share by Type (2018-2023)
Figure 46. APAC Lacosamide Tablets Sales Market Share by Application (2018-2023)
Figure 47. China Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Lacosamide Tablets Sales Market Share by Country in 2022
Figure 55. Europe Lacosamide Tablets Revenue Market Share by Country in 2022
Figure 56. Europe Lacosamide Tablets Sales Market Share by Type (2018-2023)
Figure 57. Europe Lacosamide Tablets Sales Market Share by Application (2018-2023)
Figure 58. Germany Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Lacosamide Tablets Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Lacosamide Tablets Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Lacosamide Tablets Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Lacosamide Tablets Sales Market Share by Application (2018-2023)
Figure 67. Egypt Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Lacosamide Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Lacosamide Tablets in 2022
Figure 73. Manufacturing Process Analysis of Lacosamide Tablets
Figure 74. Industry Chain Structure of Lacosamide Tablets
Figure 75. Channels of Distribution
Figure 76. Global Lacosamide Tablets Sales Market Forecast by Region (2024-2029)
Figure 77. Global Lacosamide Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Lacosamide Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Lacosamide Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Lacosamide Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Lacosamide Tablets Revenue Market Share Forecast by Application (2024-2029)